TAOX
TAO Synergies Inc. NASDAQ Listed Jul 2, 2025$6.16
Pre-mkt
$6.20
+2.82%
Mkt Cap $20.2M
52w Low $2.12
41.0% of range
52w High $11.98
50d MA $5.17
200d MA $5.99
P/E (TTM)
—
EV/EBITDA
0.6x
P/B
—
Debt/Equity
0.0x
ROE
-136.5%
P/FCF
0.0x
RSI (14)
—
ATR (14)
—
Beta
1.74
50d MA
$5.17
200d MA
$5.99
Avg Volume
182.0K
Clinical-stage biopharmaceutical company developing a bryostatin‑1 platform for Alzheimer’s and other neurodegenerative/cognitive diseases. Also pivoting to a digital-asset treasury strategy focused on acquiring and staking TAO cryptocurrency.
1185 Avenue of the Americas, 3rd Floor · New York, NY 10036 · US
Data updated apr 24, 2026 10:42am
· Source: massive.com